Who owns what employees invent? UWA v Gray v Sirtex [2008] FCA ...
Who owns what employees invent? UWA v Gray v Sirtex [2008] FCA ...
Who owns what employees invent? UWA v Gray v Sirtex [2008] FCA ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Who</strong> Owns an Academic’s<br />
Invention?<br />
Implications on IP Ownership and Commercialisation<br />
<strong>UWA</strong> v <strong>Gray</strong> & <strong>Sirtex</strong> Medical Limited<br />
(<strong>2008</strong>) 246 ALR 603 76 IPR 222<br />
Justice French, Federal Court, 17 April <strong>2008</strong><br />
Special CRC for Polymers Seminar<br />
10 July 2009<br />
Ed Heerey<br />
Victorian Bar<br />
Junior Counsel for <strong>Sirtex</strong> Medical Limited
<strong>UWA</strong> v <strong>Gray</strong> & <strong>Sirtex</strong>: the parties<br />
� Applicant: University of Western Australia<br />
� Incorporated under University of Western<br />
Australia Act 1911 (WA)<br />
� 1 st Respondent: Dr Bruce <strong>Gray</strong><br />
� 2 nd Respondent: <strong>Sirtex</strong> Medical Limited<br />
� Public company, incorp 1997, listed 2000<br />
� 3 rd Respondent: Cancer Research Institute<br />
� Charitable association
<strong>Gray</strong>’s employment by <strong>UWA</strong><br />
� January 1985 to March 1997<br />
� Full time Professor of Surgery<br />
� Based at Royal Perth Hospital (RPH)<br />
� Required to teach and to conduct and stimulate<br />
research<br />
� March 1997 to November 1999<br />
� Fractional 30% appointment focussing on clinical<br />
work at RPH
Contracts and <strong>UWA</strong> regulations<br />
� 26 October 1984 written contract<br />
� 1971 <strong>UWA</strong> Patents Regulations<br />
� employee must:<br />
� inform VC of patentable <strong>invent</strong>ion made wholly or<br />
partly during the course of that person’s duty or<br />
whilst using <strong>UWA</strong>’s research facilities<br />
� If required by <strong>UWA</strong>, assign rights to <strong>UWA</strong>
Contracts and <strong>UWA</strong> regulations<br />
� 1996 <strong>UWA</strong> IP Regulations<br />
� employee must:<br />
� promptly report the creation of any IP likely to be<br />
commercially significant<br />
� not apply for any form of protection or exploit or<br />
deal with any IP inconsistently with <strong>UWA</strong>’s rights<br />
� not apply for registration except in <strong>UWA</strong>’s name<br />
� if required, execute documents to prove <strong>UWA</strong>’s<br />
title or assist <strong>UWA</strong>’s commercialisation
<strong>UWA</strong>’s pleaded fiduciary obligations<br />
� On <strong>Gray</strong> during and after employment:<br />
� a duty to deal with the property rights and interests of<br />
<strong>UWA</strong> so as to protect and preserve that property and<br />
those rights and interests for <strong>UWA</strong><br />
� a duty not to make any secret profit or receive any secret<br />
payment or obtain any secret benefit from any third party<br />
with whom he was dealing<br />
� a duty to account for any such secret profit or secret<br />
payment or benefit<br />
� the duties of a trustee of such of <strong>UWA</strong>’s assets and<br />
property as were in his possession or control and/or under<br />
his direction from time to time
<strong>Gray</strong> and <strong>Sirtex</strong><br />
� 1997: <strong>Sirtex</strong> incorporated<br />
� 1997: <strong>Gray</strong> assigned <strong>invent</strong>ions to <strong>Sirtex</strong><br />
� 2000: Prospectus and listing on ASX<br />
� <strong>Gray</strong> a director of <strong>Sirtex</strong> from 1997 to 2007<br />
� Also Chairman, CEO and Medical Director<br />
� Since litigation started in 2004, disputes between<br />
<strong>Gray</strong> and other <strong>Sirtex</strong> directors<br />
� <strong>Sirtex</strong> cross-claim against <strong>Gray</strong> for non-disclosure<br />
of <strong>UWA</strong>’s patent claims prior to ASX listing<br />
� <strong>Gray</strong> still <strong>Sirtex</strong>’s largest shareholder
Field of technology<br />
� Treatment of liver cancer<br />
� Use of microspheres injected into hepatic<br />
artery to attack tumors in liver by:<br />
� radiation by yttrium<br />
� cytotoxic drugs (doxorubicin)<br />
� hyperthermia (heating) by magnetic hysteresis<br />
� General concepts not novel<br />
� Patents focus on specific developments
Field of technology<br />
� Key problem – radioactive microspheres<br />
� Targetting radiation to tumors, limiting radiation<br />
to other parts of the body<br />
� Radioactive yttria leaching off microspheres,<br />
travelling in blood out of liver into lungs etc<br />
� Key problem – doxorubicin microspheres<br />
� Need controlled release of drug, not burst<br />
� Key problem – hyperthermia microspheres<br />
� High magnetic fields affect nervous system
<strong>Gray</strong>’s <strong>invent</strong>ions – SIRT 1<br />
� “Selective Internal Radiation Therapy”<br />
� Method for making resin-based microspheres<br />
containing radioactive yttrium<br />
� Key <strong>invent</strong>ive concept:<br />
� use of phosphate precipitation to bind yttrium into<br />
the microspheres<br />
� addressed problem of yttrium leaching off the<br />
microspheres to other parts of body
<strong>Gray</strong>’s <strong>invent</strong>ions – SIRT 1<br />
� Idea conceived by <strong>Gray</strong> prior to 1985<br />
� ie, before employment with <strong>UWA</strong><br />
� Early 1990s, <strong>Gray</strong> supervised clinical trials<br />
at <strong>UWA</strong> (RPH)<br />
� Commercialised by <strong>Sirtex</strong><br />
� Substantial sales worldwide<br />
� <strong>Sirtex</strong> has not yet sold any other product
<strong>Gray</strong>’s <strong>invent</strong>ions – SIRT 2<br />
� Hollow or cup-shaped ceramic<br />
microspheres of pure yttrium<br />
� Addressed problem of heavy microspheres<br />
not travelling in the blood to the tumours<br />
� Idea conceived by <strong>Gray</strong> before 1985<br />
� ie before employment with <strong>UWA</strong><br />
� Early 1990s - further research with Monash<br />
� Never clinically trialled or commercialised
<strong>Gray</strong>’s <strong>invent</strong>ions – Dox Spheres<br />
� Named co-<strong>invent</strong>or on patent:<br />
� Dr Yan Chen, <strong>UWA</strong> employee<br />
� <strong>Gray</strong> claimed there were other <strong>invent</strong>ors<br />
outside <strong>UWA</strong><br />
� Key <strong>invent</strong>ive concept:<br />
� use of metal ions to suppress burst release of<br />
doxorubicin from microsphere<br />
� Never clinically trialled or commercialised
<strong>Gray</strong>’s <strong>invent</strong>ions: Thermo Spheres 1,<br />
2 and 3<br />
� Co-<strong>invent</strong>or named on patents: Steve Jones<br />
� Employed by <strong>UWA</strong> 1990 – 1997, <strong>Sirtex</strong> 1997 to present<br />
� Prior art: use of magnetic fields to cause metal<br />
microspheres to heat and kill tumors<br />
� Thermo 1: specific magnetic heating efficiency of metallic<br />
material<br />
� Thermo 2: use of certain rotational magnetic fields<br />
� Thermo 3: further developments<br />
� Tested on animals only – serious problems<br />
� Never clinically trialled or commercialised
Assignments and patent filings<br />
� 1993 – Dox Spheres patent application<br />
� 1994 – SIRT 2 patent application<br />
� 1997 – assignment by <strong>Gray</strong> to <strong>Sirtex</strong><br />
� 1997 – Thermo 1 & 2 patent application<br />
� 1999 – Thermo 3 patent application<br />
� 1999 – end of <strong>Gray</strong>’s <strong>UWA</strong> employment<br />
� 2000 – SIRT 1 patent application
French J: implied term <strong>UWA</strong> <strong>owns</strong> IP?<br />
� <strong>UWA</strong>’s case against Dr <strong>Gray</strong> and <strong>Sirtex</strong><br />
was critically dependent upon the<br />
proposition that it was an implied term of Dr<br />
<strong>Gray</strong>’s contract of employment that<br />
intellectual property developed in the<br />
course of his employment belonged to<br />
<strong>UWA</strong>.
French J: implied term <strong>UWA</strong> <strong>owns</strong> IP?<br />
� Although there seems to have been an<br />
assumption among some at <strong>UWA</strong> that such<br />
an implied term operates generally in the<br />
case of academic staff who research and<br />
use university facilities, I have concluded<br />
that the assumption is not well founded.
French J: implied term <strong>UWA</strong> <strong>owns</strong> IP?<br />
� Absent express agreement to the contrary,<br />
rights in relation to <strong>invent</strong>ions made by<br />
academic staff in the course of research<br />
and whether or not they are using<br />
university resources, will ordinarily belong<br />
to the academic staff as the <strong>invent</strong>ors<br />
under the 1990 [Patents] Act.
French J: implied term <strong>UWA</strong> <strong>owns</strong> IP?<br />
� The position is different if staff have a<br />
contractual duty to try to produce<br />
<strong>invent</strong>ions.<br />
� But a duty to research does not carry with it<br />
a duty to <strong>invent</strong>.
French J: implied term <strong>UWA</strong> <strong>owns</strong> IP?<br />
� Citing Monotti and Ricketson in Universities<br />
and Intellectual Property who expressed:<br />
� "lingering discomfort with equating an<br />
academic’s general duty to research with a duty<br />
to <strong>invent</strong>, even though the research is that from<br />
which an <strong>invent</strong>ion might reasonably be expected<br />
to result".
French J: implied term <strong>UWA</strong> <strong>owns</strong> IP?<br />
� Citing Monotti and Ricketson’s Universities<br />
and Intellectual Property:<br />
� A general obligation of secrecy may be imposed<br />
on the employee who has a duty to <strong>invent</strong>, with<br />
safeguards on the duration of secrecy.<br />
� However, an automatic implied obligation sits<br />
uncomfortably with the notion of "academic<br />
freedom", shared ownership and free exchange<br />
of research results.
French J: implied term <strong>UWA</strong> <strong>owns</strong> IP?<br />
� Citing Monotti and Ricketson in Universities<br />
and Intellectual Property:<br />
� “... in the absence of an express or implied duty<br />
to <strong>invent</strong> and to hold any information secret, the<br />
principles that operate in industrial settings seem<br />
to have no application to the creation of<br />
<strong>invent</strong>ions in the performance of normal<br />
academic duties of teaching, research and<br />
administration.”
French J: implied term <strong>UWA</strong> <strong>owns</strong> IP?<br />
� Citing Monotti and Ricketson’s Universities<br />
and Intellectual Property:<br />
� “... it will be unwise for a university to rely upon<br />
general principles if its intention is to claim title to<br />
<strong>invent</strong>ions that are made by its academic<br />
<strong>employees</strong> during their working hours and using<br />
university facilities and funding.”
French J: implied term <strong>UWA</strong> <strong>owns</strong> IP?<br />
� A person engaged to carry out research only is in<br />
a different category even when the possibility or<br />
probability exists that the research will lead to the<br />
development of an <strong>invent</strong>ion.<br />
� Such a person has a duty to research, but no duty<br />
to <strong>invent</strong>.<br />
� Where, as is often the case, the pathways that<br />
may be taken in research are a matter of choice,<br />
the question whether or not to <strong>invent</strong> will be a<br />
matter of choice.
French J: implied term <strong>UWA</strong> <strong>owns</strong> IP?<br />
� Given the nature of universities and the public<br />
purposes served by such as <strong>UWA</strong>:<br />
� no basis to imply a contractual duty for academic<br />
staff not to disclose the results of research<br />
� even if such disclosure could destroy the patentability<br />
of an <strong>invent</strong>ion.<br />
� Absent such a duty and given a choice to<br />
<strong>invent</strong> or not <strong>invent</strong>:<br />
� difficult to see basis for a term to be implied as a<br />
matter of law that the university has entitlement to the<br />
<strong>invent</strong>or’s property rights in the <strong>invent</strong>ion.
French J: implied term <strong>UWA</strong> <strong>owns</strong> IP?<br />
� Implied term even more problematical where<br />
researcher expected to secure funding from<br />
sources external to <strong>UWA</strong>.<br />
� This was even though <strong>UWA</strong> administered funding<br />
received from sources such as NH&MRC and<br />
CSIRO.<br />
� A striking feature of this case was the significant<br />
amount of time and effort devoted by Dr <strong>Gray</strong> and<br />
those researching with him in applying for<br />
research grant grants to a myriad of funding and<br />
grant bodies and agencies.
French J: <strong>Gray</strong> a “member” of <strong>UWA</strong><br />
� <strong>Gray</strong> employed by <strong>UWA</strong>, a statutory body<br />
established for public purposes.<br />
� Not merely employee, but a “member” of <strong>UWA</strong>.<br />
� Linked historically by definition of "university" in<br />
<strong>UWA</strong> Act to the idea of a university as a<br />
community of teachers and scholars.<br />
� Statutory definition traces back to the 16th<br />
century statute for Oxford University.
French J: Commercial activities of<br />
<strong>UWA</strong>?<br />
� Contemporary reality: universities, including <strong>UWA</strong>,<br />
engage in commercial activities.<br />
� Eg Quickenden v O’Connor (2001) 109 FCR 243:<br />
<strong>UWA</strong> a trading corporation for the purposes of the<br />
Workplace Relations Act 1996 (Cth).<br />
� But Quickenden considered trading activities<br />
unconnected to teaching and research.<br />
� <strong>Gray</strong> was not required to advance a <strong>UWA</strong><br />
commercial purpose when selecting the research<br />
work he would undertake.
French J: fiduciary breach?<br />
� <strong>UWA</strong>’s case for breach of fiduciary<br />
obligations rested on premise that <strong>Gray</strong><br />
was dealing with rights owned by <strong>UWA</strong>.<br />
� That premise was misconceived.<br />
� <strong>UWA</strong> failed to establish it had any rights in<br />
any of the <strong>invent</strong>ions even if made by <strong>Gray</strong><br />
in the course of employment with <strong>UWA</strong>.
French J: validity of <strong>UWA</strong> IP Regs?<br />
� <strong>UWA</strong>’s IP Regulations assert ownership by<br />
<strong>UWA</strong> of all intellectual property developed<br />
by its staff (apart from most copyright).<br />
� <strong>UWA</strong>’s Regulations which purport to vest<br />
intellectual property rights in <strong>UWA</strong> or<br />
interfere with the intellectual property<br />
generated by its academic staff, are not<br />
valid.
French J: validity of <strong>UWA</strong> Regs?<br />
� <strong>UWA</strong> was authorised, by the <strong>UWA</strong> Act, to<br />
make regulations relating to the control and<br />
management of its own property.<br />
� <strong>UWA</strong> was not authorised by the Act to<br />
make regulations acquiring property from<br />
others or interfering with their rights.
French J: how could <strong>UWA</strong> acquire IP?<br />
� The only secure way for <strong>UWA</strong> to acquire<br />
property rights from its academic staff in<br />
respect of intellectual property developed<br />
by them in the course of research at <strong>UWA</strong><br />
is by express provision in their contracts of<br />
employment.
French J: how could <strong>UWA</strong> acquire IP?<br />
� Even then, as this case demonstrates, the<br />
transaction costs of administering and<br />
enforcing such provisions and the<br />
uncertainty surrounding their scope and<br />
application, raises a real question as to<br />
their utility.
French J: how could <strong>UWA</strong> acquire IP?<br />
� The length [50 days] and complexity of this<br />
litigation has been exceptional.<br />
� However any claim by a university to<br />
intellectual property rights whose creation<br />
has involved a team of research workers,<br />
external funding, collaborative<br />
arrangements and extended periods of<br />
conceptual and practical development is<br />
likely to pose similar difficulties.
French J: how could <strong>UWA</strong> acquire IP?<br />
� <strong>UWA</strong> and other universities might well consider<br />
the alternative of deriving benefits from <strong>invent</strong>ions<br />
produced by their staff by offering highly<br />
competent and experienced commercialisation<br />
services in exchange for a negotiated interest in<br />
the relevant intellectual property.<br />
� That alternative offers many benefits in terms of<br />
incentives, harmony and certainty that are not<br />
available through the enforcement of legal rights<br />
unlikely to be capable of precise definition.
Inventions during employment?<br />
� French J accepted <strong>Sirtex</strong>’s defence that:<br />
� Only conception, not reduction to practice, gives<br />
rise to patent entitlement<br />
� The <strong>invent</strong>ive concepts for SIRT 1 & 2 were<br />
conceived before <strong>Gray</strong>’s employment at <strong>UWA</strong><br />
� All research and trials at <strong>UWA</strong> on SIRT 1 & 2 were<br />
merely reduction to practice, not conception<br />
� Thermo Spheres 1, 2 & 3 were conceived after<br />
<strong>Gray</strong>’s employment at <strong>UWA</strong>
Timing of <strong>invent</strong>ion – narrowest<br />
claim?<br />
� French J rejected <strong>UWA</strong>’s contention:<br />
� that timing of <strong>invent</strong>ion could be established by<br />
reference to the narrowest claim in patent as<br />
specifying the most specific elaboration of the<br />
<strong>invent</strong>ion [usually later in time]<br />
� French J accepted <strong>Sirtex</strong>’s submission:<br />
� analysis of entitlement should focuss on the<br />
broad “<strong>invent</strong>ive concept” [usually earlier in time]
Timing of <strong>invent</strong>ion –<br />
conception v reduction to practice<br />
� French J: “The <strong>invent</strong>ive concept marks a<br />
boundary between <strong>invent</strong>ion and<br />
verification.”<br />
� Cited US and Canadian authorities:<br />
� Wellcome discovered that AZT might work<br />
against HIV/AIDS<br />
� Idea tested and proved by US NIH scientists<br />
� NIH only reduced idea to practice<br />
� NIH not involved in conception, no entitlement
Timing of <strong>invent</strong>ion –<br />
conception v reduction to practice<br />
� French J rejected <strong>UWA</strong>’s claim by claim<br />
analysis.<br />
� cited several English decisions and Polwood v<br />
Foxworth (<strong>2008</strong>) IPR 1 on the relevance of the<br />
“<strong>invent</strong>ive concept” or “heart” of the <strong>invent</strong>ion.
Timing of <strong>invent</strong>ion –<br />
conception v reduction to practice<br />
� French J:<br />
� The “<strong>invent</strong>ion” is generally as described in the<br />
specification.<br />
� Time of <strong>invent</strong>ion and identity of <strong>invent</strong>or are<br />
ascertained by reference to that <strong>invent</strong>ive<br />
concept so described.<br />
� Time of <strong>invent</strong>ion and identity of <strong>invent</strong>or are not<br />
affected by subsequent process of reduction to<br />
practice, some elements of which may have<br />
found their way into the claims in the application.
Dox Spheres – other <strong>invent</strong>ors?<br />
� French J found Dox-Spheres <strong>invent</strong>ed<br />
during time of <strong>Gray</strong>’s employment by <strong>UWA</strong><br />
� But French J accepted <strong>Gray</strong>’s defence that:<br />
� Dox-Spheres was not in fact <strong>invent</strong>ed by Chen<br />
� Dox-Spheres co-<strong>invent</strong>ed by other persons<br />
outside <strong>UWA</strong><br />
� Dox-Spheres probably not <strong>invent</strong>ed by <strong>Gray</strong> at all
Subsequent developments<br />
� French J appointed Chief Justice of High<br />
Court of Australia<br />
� Pending Full Federal Court decision on<br />
appeal by <strong>UWA</strong> against <strong>Gray</strong><br />
� No appeal against patent owner <strong>Sirtex</strong><br />
� Appeal heard November <strong>2008</strong><br />
� Outstanding costs disputes between all<br />
parties
Subsequent developments<br />
� Commonwealth v Charlesworth [<strong>2008</strong>] APO<br />
16 (3 June <strong>2008</strong>)<br />
� S 32 & 36 application to Commissioner.<br />
� Commonwealth successfully claimed<br />
entitlement to a patent lodged by a former<br />
employee.
Subsequent developments<br />
� Commonwealth v Charlesworth (<strong>2008</strong>) 77 IPR 170<br />
� Delegate applied <strong>UWA</strong> v <strong>Gray</strong> approach to entitlement:<br />
� Identify the "<strong>invent</strong>ive concept" of <strong>invent</strong>ion.<br />
� Determine <strong>invent</strong>orship including the person responsible<br />
for the <strong>invent</strong>ive concept and the time of conception as<br />
distinct from its verification and reduction into practice.<br />
� Determine how “many” [should be “any”] contractual or<br />
fiduciary relationships between employer and <strong>invent</strong>or at<br />
time of <strong>invent</strong>orship give rise to proprietary rights claimed<br />
by employer.<br />
� NB “many” is typo by French J, now repeated by APO!
Subsequent developments<br />
� Novogen Research Pty Ltd v G.J. Consultants Pty Ltd<br />
[<strong>2008</strong>] APO 24 - opposition to patent registration<br />
� Patent Office’s approach to entitlement summarised further:<br />
� Identify the "<strong>invent</strong>ive concept" of each relevant <strong>invent</strong>ion as<br />
defined by the claims.<br />
� Determine <strong>invent</strong>orship including the person responsible for the<br />
<strong>invent</strong>ive concept and the time of conception as distinct from its<br />
verification and reduction into practice.<br />
� Determine if contractual or fiduciary relationships between the<br />
parties at the time of the <strong>invent</strong>orship give rise to the proprietary<br />
rights claimed by the opponent.<br />
� Summary avoids typo: [m]any
Subsequent developments<br />
� Other applications of <strong>UWA</strong> v <strong>Gray</strong> & <strong>Sirtex</strong> by the Patent<br />
Office in disputes over patent entitlement:<br />
� Razmik Abnoos v CSR Building Products Limited<br />
[2009] APO 7<br />
� Craige Jonathan Henrick v Granite Works Pty Ltd<br />
[<strong>2008</strong>] APO 21
Advice for public sector employers?<br />
� Review incorporating legislation<br />
� statutory purposes include the creation and<br />
commercialisation of IP?<br />
� statutory power to take IP rights from <strong>employees</strong>?<br />
� Review own employment contracts<br />
� Review assignments and licences<br />
� to other parties – valid?<br />
� from other parties – infringement of true owner’s rights?
Advice for private sector employers?<br />
� Review your employment contracts<br />
� explicit duty to <strong>invent</strong>?<br />
� explicit term vesting IP in employer?<br />
� Review rights assigned or licensed from<br />
academics, universities or other public<br />
organisations<br />
� validly assigned or licensed?<br />
� infringing true owner’s rights?
Advice for <strong>employees</strong>?<br />
� Academics and other University staff<br />
� Universities exploiting <strong>employees</strong>’ <strong>invent</strong>ions<br />
without employee’s consent?<br />
� Right to demand royalties?<br />
� Employees of other public organisations<br />
� Review employer’s enabling legislation<br />
� Compare employee to academic - duty to <strong>invent</strong>?